Issues in the Design and Implementation of Drug Formularies and Therapeutic Classes
Final Report
Presented by:
National Opinion Research Center (NORC)
at The University of Chicago
Submitted to:
Steve Sheingold
Office of the Assistant Secretary for Planning
and Evaluation (ASPE)
U.S. Department of Health and Human Services
September 2005
This report is available on the Internet at:
http://aspe.hhs.gov/health/reports/05/DrugFormularies/index.htm
Printer Friendly version of the report (in PDF format)
How to Obtain a Printed Copy
Project Team
Executive Summary (in
PDF Format)
Chapters
-
Introduction (in PDF format)
-
Classification Systems and Formularies (in PDF format)
-
Background
-
Methodology
-
Role, Structure, and Content of Classification Systems
-
The P&T Committee Process
-
Policy Implications: Classification Systems, Formularies, and P&T committees
-
The USP Classification System (in PDF format)
-
Background: How does the USP Classification System Work?
-
Policy Implications: The USP System
-
The CMS Rules for Formularies (in PDF format)
-
Background: How do the CMS Formulary Rules Work?
-
Coverage of Commonly Used Drugs Under CMS Rules
-
Policy Implications: Adequacy of Coverage Under the CMS Rules
-
Would "Real World" formularies meet CMS Rules?
-
Policy Implications: Will "Real World" Formularies Pass the CMS Tests?
-
Formulary Analysis Model (in PDF format)
-
Background
-
The Methodology: The Formulary Simulation Model
-
Prototype Formularies in the Model
-
Policy Implications: Analyzing Prototype Formularies
-
"Real World" Formularies in the Modes
-
Policy Implications: Potential for Risk Selection
-
Potential for Refining the Model
-
Conclusions and Possible future Research (in PDF format)
Appendices
- Classification Systems and Formularies
- Appendix A: Tables describing classification systems and formularies
- Appendix B: Crosswalks showing drugs as classified by different systems
- Appendix C: Information from plan interviews
- USP Classification System and CMS Rules
- Appendix D: MCBS utilization by USP class and category
- Appendix E: Commonly used drugs
- Appendix F: Do “real world” formularies meet CMS tests?
- Formulary Analysis Model
- Appendix G: Additional information on elasticity
- Appendix H: Elasticity panel members
- Appendix I: Additional information on model
- Formulary Simulation Model
To obtain a printed copy of this report, send the title and your mailing
information to:
Human Services Policy, Room 404E
Assistant Secretary for Planning and Evaluation
U.S. Department of Health and Human Services
200 Independence Av, SW
Washington, DC 20201
Fax: (202) 690-6562
Where to?
Top of Page | Contents
Main Page of Report | Contents
of Report
Home Pages:
Human Services Policy
(HSP)
Assistant Secretary for Planning and Evaluation
(ASPE)
U.S. Department of Health and Human Services
(HHS)
Last updated: 01/31/06